Competition Council approves Polisano pharmacies takeover by Sensiblu

Newsroom 27/09/2016 | 17:07

Romania’s Competition Council has approved the transaction according to which Sensiblu took over 78 pharmacies owned by Sibpharmamed SRL, part of Polisano group, according to the institution’s Facebook page.

The Council has evaluated this operation from the compatibility point of view with the competition environment and has concluded that it doesn’t bring significant obstacles in the competition from the Romanian market in pharma field.

Sensiblu is part of A&D Pharma Holdings group and its main activity is around retail trade in pharma products and the para pharma products in pharmacies.

Sibpharmamed SRL is part of Polisano group and its activity concerns the retail trade of pharma products in specialized stores.

The acquired assets are in 41 localities: Alba Iulia, Arad, Bacau, Baia Mare, Braila, Brasov, Bucuresti, Buzau, Buzias, Caransebes, Cluj-Napoca, Constanta, Craiova, Deva, Dorohoi, Focsani, Galati, Gheorgheni, Hunedoara, Iasi, Ineu, Medias, Mures, Oradea, Orastie, Petrosani, Piatra Neamt, Pitesti, Resita, Satu Mare, Sebes, Sibiu, Slatina, Targoviste, Targu Mures, Timisoara, Tulcea, Turda, Vaslui, Vulcan and Zalau.

Georgiana Bendre

BR Magazine | Latest Issue

Download PDF or read online: March 2023 Issue | Business Review Magazine

The March 2023 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “25 Leaders to Watch in 2023.” Read it online by clicking here. To
Newsroom | 09/03/2023 | 17:26

    You will receive a download link for the latest issue of Business Review Magazine in PDF format, based on the completion of the form below.

    I agree with the Privacy policy of business-review.eu

    I agree with the storage and handling of my data by business-review.eu

    Advertisement Advertisement
    Close ×

    We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

    Accept & continue